Myovant Sciences Company
Myovant Sciences developed Myfembree. Myfembree is a prescription medicine used to control heavy menstrual bleeding due to uterine fibroids in premenopausal women (before “change of life” or menopause).
Technology:
Drugs, vitamins & supplements
Industry:
Menstrual Health
Headquarters:
Brisbane, California, United States
Zip:
01-01-2016
Founded Date:
01-01-2016
Employees Number:
101-250
Funding Status:
M&A
Investors Number:
3
Total Funding:
$340,000,000
Estimated Revenue:
$10M to $50M
Last Funding Date:
2020-08-05
Last Funding Type:
Post-IPO Debt
Register and Claim Ownership